Short Interest in Wellgistics Health, Inc. (NASDAQ:WGRX) Declines By 82.9%

Wellgistics Health, Inc. (NASDAQ:WGRX) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totaling 2,676,448 shares, a decrease of 82.9% from the April 15th total of 15,634,585 shares. Currently, 2.9% of the company’s stock are short sold. Based on an average trading volume of 3,971,613 shares, the days-to-cover ratio is presently 0.7 days.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of WGRX. XTX Topco Ltd boosted its holdings in Wellgistics Health by 195.1% in the fourth quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock valued at $42,000 after purchasing an additional 70,137 shares in the last quarter. Raymond James Financial Inc. increased its holdings in Wellgistics Health by 593.8% during the 3rd quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock worth $52,000 after purchasing an additional 50,000 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Wellgistics Health by 81.0% during the fourth quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock valued at $195,000 after buying an additional 218,170 shares during the last quarter. Finally, Heights Capital Management Inc. acquired a new stake in shares of Wellgistics Health in the third quarter valued at $2,588,000.

Wellgistics Health Trading Up 23.1%

Shares of WGRX stock traded up $0.02 during mid-day trading on Wednesday, reaching $0.10. The stock had a trading volume of 181,378,560 shares, compared to its average volume of 10,710,772. Wellgistics Health has a 52-week low of $0.07 and a 52-week high of $3.00. The company has a current ratio of 0.09, a quick ratio of 0.04 and a debt-to-equity ratio of 1.86. The stock’s 50-day moving average price is $0.13 and its two-hundred day moving average price is $0.35. The firm has a market capitalization of $12.29 million, a PE ratio of -0.07 and a beta of -1.17.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Wellgistics Health in a research note on Friday, March 27th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Wellgistics Health Company Profile

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.